The Role of Regulatory T Cells During the Course of BK Viremia in Renal Transplant Recipients.

被引：0
|
作者：
Caliskan, Y. [1 ]
Caliskan, B. [2 ]
Kiran, B. [3 ]
Ayna, T. [4 ]
Ciftci, H. [4 ]
Yazici, H. [1 ]
Turkmen, A. [1 ]
Sever, M. [1 ]
机构：
[1] Istanbul Univ, Fac Med, Div Nephrol, Dept Internal Med, Istanbul, Turkey
[2] Istanbul Fac Med, Div Pediat Infect Dis, Dept Pediat, Istanbul, Turkey
[3] Istanbul Fac Med, Dept Med Microbiol, Istanbul, Turkey
[4] Istanbul Fac Med, Dept Med Biol, Istanbul, Turkey
来源：
TRANSPLANTATION | 2014年 / 98卷
关键词：
D O I：
10.1097/00007890-201407151-01866
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
B1022
引用
收藏
页码：556 / 556
页数：1
相关论文
共 50 条
  • [41] Relationship between HLA antibodies and regulatory T cells in kidney transplant recipients.
    Crispin, JC
    Rojas, MIV
    Romero, JMB
    Buenrostro, LEM
    Alberú, J
    Varela, JA
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 501 - 501
  • [42] LEFLUNOMIDE IMMUNE THERAPY FOR THE TREATMENT OF BK VIREMIA AND PREVENTION OF BK NEPHROPATHY IN PEDIATRIC AND YOUNG ADULT KIDNEY TRANSPLANT RECIPIENTS.
    Bock, M.
    Moss, M.
    Matossian, D.
    Goebel, J.
    Bobrowski, A.
    PEDIATRIC TRANSPLANTATION, 2017, 21 : 83 - 83
  • [43] Time Dependent Pharmacodynamic Responses of T Regulatory Cells in Stable African American and Caucasian Renal Transplant Recipients.
    Tornatore, Kathleen
    Sudchada, Patcharaporn
    Gundroo, Aijaz
    Gray, Vanessa
    Attwood, Kris
    Wallace, Paul
    Venuto, Rocco
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 515 - 515
  • [44] Monthly screening for BK viremia is an effective strategy to prevent BK virus nephropathy in renal transplant recipients
    Almeras, C.
    Vetromile, F.
    Garrigue, V.
    Szwarc, I.
    Foulongne, V.
    Mourad, G.
    TRANSPLANT INFECTIOUS DISEASE, 2011, 13 (02) : 101 - 108
  • [45] Screening for BK Viremia/Viruria and the Impact o Management of BK Virus Nephropathy in Renal Transplant Recipients
    Zakaria, Zakaria E.
    Elokely, Amir M.
    Ghorab, Adel A.
    Bakr, Adel, I
    Halim, Medhat A.
    Gheith, Osama A.
    Nagib, Ayman M.
    Makkeyah, Yahya
    Balaha, Mohamed A.
    Magdy, Mahmoud M.
    Al-Otaibi, Torki
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2019, 17 : 83 - 91
  • [46] Efficacy of Intravenous lmmunoglobulin in the Treatment of Persistent BK Viremia and BK Virus Nephropathy in Renal Transplant Recipients
    Vu, D.
    Shah, T.
    Ansari, J.
    Naraghi, R.
    Min, D.
    TRANSPLANTATION PROCEEDINGS, 2015, 47 (02) : 394 - 398
  • [47] Clinical course and management of viral hepatitis in renal transplant recipients.
    Rao, VK
    KIDNEY INTERNATIONAL, 1999, 55 (05) : 2123 - 2124
  • [48] BK Polyoma Virus Infection and Efficacy of Leflunomide in Pediatric Renal Transplant Recipients.
    Crowther, B.
    Hall, R.
    Arar, M.
    Ranch, D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 434 - 434
  • [49] Longitudinal Single-Cell Profiling of CD8 T Cells During CMV Viremia in Kidney Transplant Recipients.
    Sun, Y.
    Sen, S.
    Pickering, H.
    Parmar, R.
    Reed, E.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 539 - 540
  • [50] Deceased-Donor Acute Kidney Injury Associates with Less BK Viremia in Kidney Transplant Recipients.
    Hall, I. E.
    Reese, P. P.
    Mansour, S. G.
    Mohan, S.
    Doshi, M. D.
    Jia, Y.
    Thiessen-Philbrook, H. R.
    Akalin, E.
    Harhay, M. N.
    Muthukumar, T.
    Schroppel, B.
    Singh, P.
    Weng, F. L.
    Bromberg, J. S.
    Parikh, C. R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 545 - 545
12345